c-Myc is Required for BRAF<sup>V600E</sup>-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis

Yiping Qu(First Affiliated Hospital of Xi'an Jiaotong University), Peng Hou(First Affiliated Hospital of Xi'an Jiaotong University)
Theranostics
January 1, 2017
10.7150/thno.19884
Cited by 37

Related Papers

Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway
|BMC Cancer|2013|75
Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells
|Endocrine Related Cancer|2011|75
Hypoxia switches TET1 from being tumor-suppressive to oncogenic
|Oncogene|2023|23
Targeting METTL3 enhances the chemosensitivity of non-small cell lung cancer cells by decreasing ABCC2 expression in an m<sup>6</sup>A-YTHDF1-dependent manner
|International Journal of Biological Sciences|2024|17
<i>PAX3</i> is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer
|Oncotarget|2016|15